Pharma M&A: The top high value deals in 2023 [Yahoo! Finance]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Yahoo! Finance
total deal values reached $264bn, mergers and acquisitions (M&As) saw somewhat of a resurgence in 2023. While there was a rebound in M&A deals from 2022 to 2023 in terms of total deal values was observed, M&A activity in Q1 2024 has dropped in comparison to Q1 2023 in terms of deal values. Oncology as a therapeutic area has consistently attracted the most deals over the years, with 2023's highest-value deal also being in the cancer arena. At the same time, there was growing interest for M&As neurology and immunology last year. Following a dip in deal activity during the Covid-19 pandemic, the value of all M&A deals in the pharmaceutical space last year reached $184bn, while the top ten highest value deals totaled approximately $121bn. In this feature, we analyse publicly available data focusing only on the biggest M&As that were completed in 2023. 1. Pfizer's acquisition of Seagen - $43bn Pfizer and Seagen's $43bn deal spurred significant interest in the field of antibody
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- What to know about the XEC Covid variant gaining traction in the U.S. [MSNBC.com]MSNBC.com
- Tax Cuts - An Examination Of The 2017 TCJA Impact [zero hedge]zero hedge
- What to know about the XEC Covid variant [MSNBC.com]MSNBC.com
- Agios cut at Leerink on overhang from Pfizer's Oxbryta withdrawal [Seeking Alpha]Seeking Alpha
- Biopharmaceutical Market Size Projected to Reach USD 17,902.42 Billion by 2032 with 49.60% CAGR – SNS Insider [Yahoo! Finance]Yahoo! Finance
PFE
Earnings
- 7/30/24 - Beat
PFE
Sec Filings
- 9/16/24 - Form 4
- 9/16/24 - Form 4
- 9/16/24 - Form 4
- PFE's page on the SEC website